Magna-Lab (OTCMKTS:MAGAA) and Fonar (NASDAQ:FONR) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, analyst recommendations, profitability, dividends and risk.
This is a summary of current recommendations and price targets for Magna-Lab and Fonar, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Earnings & Valuation
This table compares Magna-Lab and Fonar’s top-line revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Fonar||$81.52 million||1.65||$21.23 million||N/A||N/A|
Fonar has higher revenue and earnings than Magna-Lab.
Risk and Volatility
Magna-Lab has a beta of 8.72, meaning that its stock price is 772% more volatile than the S&P 500. Comparatively, Fonar has a beta of 0.88, meaning that its stock price is 12% less volatile than the S&P 500.
This table compares Magna-Lab and Fonar’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Institutional and Insider Ownership
51.6% of Fonar shares are held by institutional investors. 15.3% of Magna-Lab shares are held by company insiders. Comparatively, 8.6% of Fonar shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Fonar beats Magna-Lab on 6 of the 8 factors compared between the two stocks.
Magna-Lab, Inc. is a shell company, which intends to identify and merge with an operating company. The company was founded by Lawrence A. Minkoff on February 22, 1991 and is headquartered in Syosset, NY.
FONAR Corporation, together with its subsidiaries, operates as a magnetic resonance imaging (MRI) company primarily in the Unites States. It is involved in the research, development, production, and marketing of medical scanning equipment, which uses principles of MRI for the detection and diagnosis of human diseases, abnormalities, other medical conditions, and injuries. The company operates in two segments, Manufacturing and Servicing of Medical Equipment, and Management of Diagnostic Imaging Centers. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company markets its scanners to private diagnostic imaging centers and hospitals. It also provides non-medical management services, including development, administration, office space leasing, facilities, equipment, supplies, staffing, credentialing, accounting, billing and collection, assistance with compliance matters, and practice growth and marketing strategies development and implementation services, as well as engages in the training and supervision of non-medical personnel for diagnostic imaging facilities. The company also exports its products to the United Arab Emirates, Switzerland, Canada, England, Germany, and Puerto Rico. It owns and operates 4 diagnostic imaging facilities in Florida; and manages 26 MRI scanning facilities, including 19 facilities located in New York and 7 situated in Florida. The company was founded in 1978 and is based in Melville, New York.
Receive News & Ratings for Magna-Lab Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Magna-Lab and related companies with MarketBeat.com's FREE daily email newsletter.